ANG-3281

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameANG-3281
Drug Alias NameCYP26 inhibitors (Angion Biomedica)retinoic acid signalling modulator (Angion)ANG-3281
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 26 inhibitors
TargetsCytochrome P450 26
Therapy Area/IndicationsWounds and InjuriesFibrosisKidney Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesElicio Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesFibrosisKidney Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A